Quetiapine Fumarate Extended-release Tablet Formulation Design Using Artificial Neural Networks

Objectives: This design study was implemented within the scope of the quality by design approach, which included the “International Conference on Harmonization” guidelines. We evaluated the quality of a modified-release tablet formulation of quetiapine fumarate, which was designed using artificial neural networks (ANN), and determined a new formulation that was similar to the reference product. Materials and Methods: Twelve different formulations were produced and tested. The reference product’s results and our experimental results were used as outputs for the training of the ANN programs of Intelligensys Ltd. Results: Dissolution tests were performed with the new formulation (F13) suggested by the INForm V.4 ANN program in three different pHs of the gastrointestinal system. The compliance of this formulation was confirmed by comparing the results with an f2 similarity test. Conclusion: Use of these programs supports research and development processes with multiple evaluation methods and alternative formulations may be determined faster and at lower cost.

[1]  W. Liang,et al.  Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[2]  T Nagai,et al.  Formula optimization of theophylline controlled-release tablet based on artificial neural networks. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Rakesh Kumar,et al.  Preparation and evaluation of floating tablets of pregabalin , 2016, Drug development and industrial pharmacy.

[4]  Buket Aksu,et al.  Quality by design approach for tablet formulations containing spray coated ramipril by using artificial intelligence techniques , 2012 .

[5]  A. Larsson,et al.  Influence of Different Polymer Types on the Overall Release Mechanism in Hydrophilic Matrix Tablets , 2009, Molecules.

[6]  H. Wen,et al.  Oral controlled release formulation design and drug delivery : theory to practice , 2010 .

[7]  Celil Tan,et al.  Development of sustained release formulation of an antithrombotic drug and application of fuzzy logic , 2012, Pharmaceutical development and technology.

[8]  K. Peh,et al.  Application of Similarity Factor in Development of Controlled-Release Diltiazem Tablet , 2000, Drug development and industrial pharmacy.

[9]  Torben Schæfer,et al.  Granulation: A Review on Pharmaceutical Wet-Granulation , 1987 .

[10]  R. L. Robinson,et al.  Virtual Design of Chemical Penetration Enhancers for Transdermal Drug Delivery , 2012, Chemical biology & drug design.

[11]  Diane J Burgess,et al.  Quality by design approach to understand the process of nanosuspension preparation. , 2009, International journal of pharmaceutics.

[12]  J. Comer,et al.  Study of pH-dependent solubility of organic bases. Revisit of Henderson-Hasselbalch relationship. , 2010, Analytica chimica acta.

[13]  Lawrence X. Yu.  Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control , 2008, Pharmaceutical Research.

[14]  N. Sandler,et al.  Rapid Particle Size Measurement Using 3D Surface Imaging , 2011, AAPS PharmSciTech.

[15]  P. S. Hiremath,et al.  Controlled Release Hydrophilic Matrix Tablet Formulations of Isoniazid: Design and In Vitro Studies , 2008, AAPS PharmSciTech.

[16]  Chee Peng Lim,et al.  Use of Artificial Neural Networks to Predict Drug Dissolution Profiles and Evaluation of Network Performance Using Similarity Factor , 2000, Pharmaceutical Research.

[17]  T. Pal,et al.  Optimization of metformin HCl 500 mg sustained release matrix tablets using Artificial Neural Network (ANN) based on Multilayer Perceptrons (MLP) model. , 2008, Chemical & pharmaceutical bulletin.

[18]  J. Casas,et al.  Xanthan gum: production, recovery, and properties. , 2000, Biotechnology advances.

[19]  H. Wu,et al.  On-line Process Control and Process Analytical Technology : Integration of Chemical Engineering Practice into Semiconductor and Pharmaceutical Industries , 2004 .

[20]  Buket Aksu,et al.  A quality by design approach using artificial intelligence techniques to control the critical quality attributes of ramipril tablets manufactured by wet granulation , 2013, Pharmaceutical development and technology.

[21]  Q Shao,et al.  Investigation of an artificial intelligence technology--Model trees. Novel applications for an immediate release tablet formulation database. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  V. K. Handa,et al.  Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate. , 2008, Die Pharmazie.

[23]  Abdullah Al Mamun,et al.  In-process and finished products quality control tests for pharmaceutical tablets according to Pharmacopoeias , 2016 .

[24]  Raymond C Rowe,et al.  Neural Computing and Formulation Optimization , 2013 .

[25]  Jonas S Almeida,et al.  Predictive non-linear modeling of complex data by artificial neural networks. , 2002, Current opinion in biotechnology.

[26]  R. Guy,et al.  International Conference on Harmonisation , 2014 .

[27]  G E Peck,et al.  Pharmaceutical granulation and tablet formulation using neural networks. , 1996, Pharmaceutical development and technology.

[28]  S. Pandey,et al.  DESIGN AND EVALUATION OF BUCCOADHESIVE CONTROLLED RELEASE FORMULATIONS OF PROCHLORPERAZINE MALEATE , 2015 .

[29]  P. York,et al.  Quality by Design Approach: Application of Artificial Intelligence Techniques of Tablets Manufactured by Direct Compression , 2012, AAPS PharmSciTech.